Anchiano Therapeutics
  • Home
  • About Us
    • The Company
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • Our Science
    • Pan-RAS Program
    • PDE10/β-catenin Program
  • Pipeline
    • Overview
    • Small Molecule Pan-RAS Inhibitors
    • Small Molecule PDE10/β-catenin Inhibitors
  • Investors
    • Investor Relations
    • Presentations and Events
    • Press Releases
    • SEC Company Filings
    • Selected Publications
  • Home
  • About Us
    • The Company
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • Our Science
    • Pan-RAS Program
    • PDE10/β-catenin Program
  • Pipeline
    • Overview
    • Small Molecule Pan-RAS Inhibitors
    • Small Molecule PDE10/β-catenin Inhibitors
  • Investors
    • Investor Relations
    • Presentations and Events
    • Press Releases
    • SEC Company Filings
    • Selected Publications

Form 6-K

Anchiano Therapeutics Ltd. filed this Form 6-K on 05/28/2019

Document Outline:

PDF Form 6-K (LINK)

PDF Exhibit 99.1  (LINK) 

PDF Exhibit 99.2  (LINK) 

PDF Exhibit 99.3  (LINK) 

PDF Graphic  (LINK) 

PDF Graphic  (LINK) 

PDF Graphic  (LINK) 

PDF Complete Text Submission File  (LINK) 

 

 

Website Terms and Conditions of Use

View Online
Download PDF

 

 

Contact Us

Ph: 857-259-4622

Email: info@anchiano.com

Address: One Kendall Square, Building 1400E, Suite 14-105, Cambridge, MA 02139 (map)

Investor relations:
Email: info@anchiano.com

Anchiano Therapeutics © 2021